Cargando…

Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy

BACKGROUND: Urinary sediment messenger RNAs (mRNAs) have been shown as novel biomarkers of kidney disease. We aimed to identify targeted urinary mRNAs in diabetic nephropathy (DN) based on bioinformatics analysis and clinical validation. METHODS: Microarray studies of DN were searched in the GEO dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Song-Tao, Yang, Yang, Yang, Jin-Fei, Gao, Yue-Ming, Cao, Jing-Yuan, Li, Zuo-Lin, Tang, Tao-Tao, Lv, Lin-Li, Wang, Bin, Wen, Yi, Sun, Lin, Xing, Guo-Lan, Liu, Bi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862108/ https://www.ncbi.nlm.nih.gov/pubmed/35211307 http://dx.doi.org/10.1093/ckj/sfab186

Ejemplares similares

Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy
por: Feng, Ye, et al.
Publicado: (2021)

Non-invasive urinary sediment double-immunostaining predicts BK polyomavirus associated-nephropathy in kidney transplant recipients
por: Chen, Xu-Tao, et al.
Publicado: (2020)

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)

Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2010)

Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy
por: Liang, Shuang, et al.
Publicado: (2017)

Comprehensive Analysis of Therapy-Related Messenger RNAs and Long Noncoding RNAs as Novel Biomarkers for Advanced Colorectal Cancer
por: Li, Jibin, et al.
Publicado: (2019)

Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease
por: Zhou, Le-Ting, et al.
Publicado: (2019)

Identification of CCL19 as a Novel Immune-Related Biomarker in Diabetic Nephropathy
por: Chen, Hanzhi, et al.
Publicado: (2022)

Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy
por: Li, Tao, et al.
Publicado: (2023)

Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy
por: Han, Qiuxia, et al.
Publicado: (2021)

Development and External Validation of a Nomogram and a Risk Table for Prediction of Type 2 Diabetic Kidney Disease Progression Based on a Retrospective Cohort Study in China
por: Gao, Yue-Ming, et al.
Publicado: (2022)

Novel Biomarkers in Membranous Nephropathy
por: Liu, Qiuying, et al.
Publicado: (2022)

Detection of Proximal Tubule Involvement by BK Polyomavirus in Kidney Transplant Recipients With Urinary Sediment Double-Immunostaining
por: Huang, Yang, et al.
Publicado: (2020)

Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy
por: Zheng, Min, et al.
Publicado: (2011)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy
por: Shao, Mingmei, et al.
Publicado: (2020)

Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2018)

Urinary Angiotensinogen as a Biomarker of Nephropathy in Childhood
por: Urushihara, Maki, et al.
Publicado: (2011)

Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy
por: Gluhovschi, Cristina, et al.
Publicado: (2016)

Urinary cMet as a prognostic marker in immunoglobulin A nephropathy
por: An, Jung Nam, et al.
Publicado: (2020)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
por: Zhang, Jun-yi, et al.
Publicado: (2019)

The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
por: Lu, Tao, et al.
Publicado: (2016)

Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study
por: Bi, Tong-dan, et al.
Publicado: (2019)

survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma
por: Ikeguchi, M, et al.
Publicado: (2002)

CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma
por: Tong, Junyu, et al.
Publicado: (2022)

Redox-associated messenger RNAs identify novel prognostic values and influence the tumor immune microenvironment of lung adenocarcinoma
por: Zhao, Chen, et al.
Publicado: (2023)

Diagnostic roles of urinary kidney microvesicles in diabetic nephropathy
por: Cai, Fang-Hao, et al.
Publicado: (2020)

Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis
por: Zhang, Lin, et al.
Publicado: (2015)

ALPK1 regulates streptozotocin‐induced nephropathy through CCL2 and CCL5 expressions
por: Lee, Chi‐Pin, et al.
Publicado: (2019)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Systematic Analysis of Chemokines Reveals CCL18 is a Prognostic Biomarker in Glioblastoma
por: Gao, Wenqing, et al.
Publicado: (2022)

Use and Isolation of Urinary Exosomes as Biomarkers for Diabetic Nephropathy
por: Musante, Luca, et al.
Publicado: (2014)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy
por: Imaizumi, Takahiro, et al.
Publicado: (2016)

Urinary Biomarkers for the Noninvasive Detection of Gastric Cancer
por: Li, Dehong, et al.
Publicado: (2022)

Atlas of Urinary Sediments
Publicado: (1900)

A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy
por: Zheng, Min, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1plh82e3j5g6qhls6ue4ijjrp1